血管性血友病因子(vWF)重组蛋白

血管性血友病因子(vWF)重组蛋白

Recombinant Von Willebrand Factor (vWF)

F8VWF; VWD; von Willebrand antigen 2

[ PROPERTIES ]

Source: Prokaryotic expression. Host: E. coli

Residues: Asp1498~Val1665

Tags: N-terminal His-Tag

Tissue Specificity: Blood. Subcellular Location: Secreted, extracellular space, extracellular matrix. Purity: >92%

Traits: Freeze-dried powder

Buffer formulation: PBS, pH7.4, containing 1mM DTT, 5% trehalose, 0.01%

sarcosyl and Proclin300. Original Concentration: 200ug/mL

Applications: SDS-PAGE; WB; ELISA; IP; CoIP; ReporterAssays; Purification;

Amine Reactive Labeling. (May be suitable for use in other assays to be determined by the end user.)

Predicted isoelectric point: 5.0

Predicted Molecular Mass: 20.4kDa

Accurate Molecular Mass: 18kDa as determined by SDS-PAGE reducing conditions.

[ USAGE ]

Reconstitute in PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

[ STORAGE AND STABILITY ]

Storage: Avoid repeated freeze/thaw cycles. Store at 2-8

oC for one month. Aliquot and store at -80

oC for 12 months. 

Stability Test: The thermal stability is described by the loss rate. The loss ratewas determined by accelerated thermal degradation test, that is, incubate theprotein at 37oC for 48h, and no obvious degradation and precipitation wereobserved.The loss rate is less than 5% within the expiration date under

appropriate storage condition. 

[ SEQUENCE ]

特别提示：本公司的所有产品仅可用于科研实验，严禁用于临床医疗及其他非科研用途！